147 related articles for article (PubMed ID: 14965064)
1. [Evolution of antipsychotic drug consumption in the autonomous community of Castile and Leon, Spain (1990-2001)].
García del Pozo J; Isusi Lomas L; Carvajal García-Pando A; Martín Rodríguez I; Sáinz Gil M; García del Pozo V; Velasco Martín A
Rev Esp Salud Publica; 2003; 77(6):725-33. PubMed ID: 14965064
[TBL] [Abstract][Full Text] [Related]
2. A pharmacoepidemiological study of the consumption of antiparkinson drugs in the Basque Autonomous Community (Spain) (1992-2004).
Osinaga EA; Inchaurregui LC; Ikobaltzeta IE; Alonso NB; Del Pozo JG
Parkinsonism Relat Disord; 2007 Dec; 13(8):500-4. PubMed ID: 17532251
[TBL] [Abstract][Full Text] [Related]
3. [Consumption and cost of antipsychotic drugs].
Pérez J; Marín N; Vallano A; Castells X; Capellà D
Actas Esp Psiquiatr; 2005; 33(2):110-6. PubMed ID: 15768318
[TBL] [Abstract][Full Text] [Related]
4. [Use of antihypertensive drugs in Spain (1995-2001)].
García del Pozo J; Ramos Sevillano E; de Abajo FJ; Mateos Campos R
Rev Esp Cardiol; 2004 Mar; 57(3):241-9. PubMed ID: 15056428
[TBL] [Abstract][Full Text] [Related]
5. [Changes in the pattern of opioid analgesic consumption in Spain].
Carvajal A; García del Pozo J; Martín Arias LH; Martín de Diego I; Rueda AM; Caro-Patón T; Alvarez Requejo A
Med Clin (Barc); 1997 Sep; 109(8):281-3. PubMed ID: 9379748
[TBL] [Abstract][Full Text] [Related]
6. Antipsychotic use at adult ambulatory care visits by patients with mental health disorders in the United States, 1996-2003: national estimates and associated factors.
Sankaranarayanan J; Puumala SE
Clin Ther; 2007 Apr; 29(4):723-41. PubMed ID: 17617297
[TBL] [Abstract][Full Text] [Related]
7. Use of antipsychotic agents in Spain through 1985-2000.
Santamaría B; Pérez M; Montero D; Madurga M; de Abajo FJ
Eur Psychiatry; 2002 Dec; 17(8):471-6. PubMed ID: 12504264
[TBL] [Abstract][Full Text] [Related]
8. [A pharmacoepidemiological study of antiepileptic drug consumption (1992-2004)].
Abasolo-Osinaga E; Abecia-Inchaurregui LC; Etxeandia-Ikobaltzeta I; Burgos-Alonso N; García-del Pozo J
Rev Neurol; 2008 Apr 16-30; 46(8):449-53. PubMed ID: 18428100
[TBL] [Abstract][Full Text] [Related]
9. [The use of anxiolytic and hypnotic drugs in Spain (1995-2002)].
García del Pozo J; de Abajo Iglesias FJ; Carvajal García-Pando A; Montero Corominas D; Madurga Sanz M; García del Pozo V
Rev Esp Salud Publica; 2004; 78(3):379-87. PubMed ID: 15293958
[TBL] [Abstract][Full Text] [Related]
10. The unintended (and costly) effects due to the introduction of an unrestricted reimbursement policy for atypical antipsychotic medications in a Canadian public prescription drug program: 1996/97 to 2005/06.
O'Reilly DJ; Goeree RA; Tarride JE; James C; Parfrey PS
Can J Clin Pharmacol; 2009; 16(2):e346-59. PubMed ID: 19531813
[TBL] [Abstract][Full Text] [Related]
11. Prevalence, incidence and persistence of antipsychotic drug prescribing in the Italian general population: retrospective database analysis, 1999-2002.
Mirandola M; Andretta M; Corbari L; Sorio A; Nosè M; Barbui C
Pharmacoepidemiol Drug Saf; 2006 Jun; 15(6):412-20. PubMed ID: 16287199
[TBL] [Abstract][Full Text] [Related]
12. Impact of regulatory measures on antipsychotics drug consumption in Castilla y León, Spain.
Martín Arias LH; Treceño Lobato C; Pérez García S; García Ortega P; Sáinz Gil M; Sanz Fadrique R; Carvajal García-Pando A
Public Health; 2016 Dec; 141():113-119. PubMed ID: 27931985
[TBL] [Abstract][Full Text] [Related]
13. Hospitalization risk associated with typical and atypical antipsychotic use in community-dwelling elderly patients.
Aparasu RR; Jano E; Johnson ML; Chen H
Am J Geriatr Pharmacother; 2008 Oct; 6(4):198-204. PubMed ID: 19028375
[TBL] [Abstract][Full Text] [Related]
14. Antipsychotic medication coprescribing in a large state hospital system.
Jaffe AB; Levine J
Pharmacoepidemiol Drug Saf; 2003; 12(1):41-8. PubMed ID: 12616846
[TBL] [Abstract][Full Text] [Related]
15. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
Bret P; Bret MC; Queuille E
Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
[TBL] [Abstract][Full Text] [Related]
16. Role of patient experience in atypical antipsychotic adherence: a retrospective data analysis.
Vanelli M; Coca-Perraillon M; Troxell-Dorgan A
Clin Ther; 2007 Dec; 29(12):2768-73. PubMed ID: 18201595
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology and characteristics of emergency departments visits by US adults with psychiatric disorder and antipsychotic mention from 2000 to 2004.
Sankaranarayanan J; Puumala SE
Curr Med Res Opin; 2007 Jun; 23(6):1375-85. PubMed ID: 17594776
[TBL] [Abstract][Full Text] [Related]
18. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
19. [Use of specific drugs for Alzheimer's disease].
Villar Fernández I; Rabaneque Hernández MJ; Armesto Gómez J; García Arilla E; Izuel Rami M
Neurologia; 2007 Jun; 22(5):275-84. PubMed ID: 17508301
[TBL] [Abstract][Full Text] [Related]
20. If 'atypical' neuroleptics did not exist, it wouldn't be necessary to invent them: perverse incentives in drug development, research, marketing and clinical practice.
Charlton BG
Med Hypotheses; 2005; 65(6):1005-9. PubMed ID: 16182461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
